Relay Therapeutics, Inc. RLAY Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$276.48M+18.1% | -$337.71M+1.2% | -$341.97M-17.7% | -$290.51M+20.2% | ||
| $3.56M-34.9% | $5.46M+3.7% | $5.27M+27.6% | $4.13M+5.2% | ||
| $62.42M-33.7% | $94.14M+9.4% | $86.03M+53.2% | $56.14M+15.9% | ||
| -$235.46M+5.5% | -$249.11M+17.1% | -$300.32M-30.9% | -$229.49M-208% | ||
| $411K-79.6% | $2.02M-51.1% | $4.13M-54.5% | $9.06M+161% | ||
| $192.8M— | —— | $257.63M— | —— | ||
| —— | $270.15M+677% | $34.75M-88.0% | $289.91M-25.3% | ||
| —— | -$20.04M— | —— | -$128.33M— | ||
| -$235.87M+6.1% | -$251.13M+17.5% | -$304.44M-27.6% | -$238.55M-206% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Relay Therapeutics, Inc. generate?
- Relay Therapeutics, Inc. (RLAY) generated -$213.4M in operating cash flow over the trailing twelve months.
- Where does Relay Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
